HOME >> BIOLOGY >> NEWS
New genetic hypothesis for the cause of autism

Researchers have proposed a new hypothesis on the cause of autism, suggesting a mixed epigenetic and genetic and mixed de novo and inherited (MEGDI) model. Their hypothesis, and evidence to support it, will be published September 8, 2004 in the online edition of the American Journal of Medical Genetics Part A, and will be available via Wiley InterScience at http://www.interscience.wiley.com/journal/ajmg.

The role of genetics in autism is believed to be significant because twin studies have found that identical twins, who have the same DNA, are much more likely to share the diagnosis than fraternal twins. However, experts have not yet identified the specific genetic components related to autism, and many experts believe that multiple genes are involved.

Researchers, led by Yong-hui Jiang of Baylor College of Medicine in Houston, propose that most cases of autism can be explained by a complex model for genetic malfunction that may or may not include an altered DNA sequence. Where the DNA sequence is intact, the researchers believe that gene expression could be faulty. They suggest that some of these genetic factors are inherited, and others occur de novo in genes of the autistic person. In this study, they formulate a five-part hypothesis on the cause of autism:

Based on the evidence of parent-of-origin effects, they propose that there is a major epigenetic (related to gene expression, not sequence) component in the etiology of autism involving genetic imprinting.

They suggest that epigenetic and genetic factors (both de novo and inherited) cause autism through dysregulation of two or more principal genes, one of which maps within chromosomes 15q11-q13, with the Angelman gene encoding E6-AP ubiquitin-protein ligase (UBE3A) being the strongest candidate in this region

They propose that the dysregulation of UBE3A involves some combination of overexpression, gene silen
'"/>

Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
8-Sep-2004


Page: 1 2 3

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Rare childhood genetic syndrome identified
3. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
4. Scientists decipher genetic code of biothreat pathogen
5. Chemical genetics identifies SARS inhibitors
6. 22nd amino acid synthesized and added to genetic code of e. coli bacteria
7. The impact of genetic variations on the treatment of early rheumatoid arthritis
8. Adaptive changes in the genome may provide insight into the genetics of complex disease
9. Fossils reveal direct link between global warming and genetic diversity in wildlife
10. A genetic disorder yields insight into genes and cognition
11. Study reveals first genetic step necessary for prostate cancer growth

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/22/2019)... NEW ORLEANS (PRWEB) , ... October 21, 2019 , ... ... cancer with the launch of two, new navigated instruments. These devices are designed to ... lung cancer. These new tip-tracked tools will be launched at the annual American College ...
(Date:10/22/2019)... TORONTO (PRWEB) , ... October 21, 2019 , ... Join ... Ingen, MS, Director of Bioanalytical in a live session on Thursday, October ... bioanalysis CRO partner. , A good CRO partner should have expertise in method ...
(Date:10/22/2019)... , ... October 22, 2019 , ... ... the 71st Southeastern Regional Meeting of the American Chemical Society, ( SERMACS ) ... a variety of symposia topics covering analytical, biological, computational, inorganic, medicinal, organic, physical, ...
Breaking Biology News(10 mins):
(Date:10/22/2019)... , ... October 22, 2019 , ... nQ Medical, Inc. ... School’s 2019 Most Fundable Companies List which was announced at a showcase event yesterday ... million in annual revenue, strong business plans, and impressive near-term growth projections to be ...
(Date:10/22/2019)... N.J. (PRWEB) , ... October 22, 2019 , ... Catalent, ... Clinical Supply Services and Drug Product Technologies Integration, will participate in a panel session ... Conference (HPCLC), to be held at the Gwen Hotel, Chicago, on Oct. 28-30, 2019. ...
(Date:10/22/2019)... LOS ANGELES (PRWEB) , ... October 22, 2019 ... ... software provider, today announced integration of the Alertus Mass Notification System into its ... critical infrastructure to the Enplug platform, making it possible for users to leverage ...
(Date:10/22/2019)... ... , ... DermBiont, a clinical stage microbiome biotechnology company developing ... safety endpoints, with no application site reactions and no adverse events, in a ... tinea pedis (athlete’s foot). Additionally, the trial demonstrated a clinical response with improvement ...
Breaking Biology Technology:
Cached News: